Home / Latest Reports / Niacin And Niacinamide Market

Niacin And Niacinamide Market By Form (granular, Powder, Liquid) And End User (pharmaceuticals, Cosmeceuticals, Human Nutrition, Animal Nutrition) - Global Industry Analysis And Forecast To 2023

Published On : June 2022 Pages : 172 Category: Biotechnology Report Code : HC061009

Request Sample Inquiry Before Buying Request for Customization Check Discount

Industry Outlook and Trend Analysis

The Niacin and Niacinamide Market has encountered significant development in the recent years and is anticipated to grow tremendously over the forecast period. Niacin is a natural compound, and thought to be a standout amongst the most fundamental nutrients for humans, as niacin insufficiency causes pellagra. Niacinamide, an amide of niacin, is likewise alluded to as nicotinic acid amide or nicotinamide. Niacin and niacinamide are indispensable segments of Vitamin B3, and are frequently used as supplements reciprocally. These are generally found in many food products, for example, fish, eggs, meat, beans, green vegetables, and yeast. Niacin and niacinamide are additionally looked for in different vitamin supplements, especially in vitamin B-complex supplements.

Drivers and Restraints

Niacin and Niacinamide have been affirmed by the U.S. Food and Drug Administration for curing patients with pellagra which is one the major drivers of the market. Throughout the years, niacin has stayed well-recognized for treating people with high cholesterols; nonetheless ongoing investigations have exhibited niacin to have unfriendly symptoms when used to treat cholesterol levels. In nations with malnutrition being one of the real concerns, administrative bodies are setting up rules for food fortification including edible milk, oil, wheat flour, salt, and rice. Consideration of niacin and niacinamide in major parts of these food products is one of the parts of nourishment fortress in these nations, keeping in mind the end goal to avert vitamin B3 lack.

Market Segmentation

The Niacin and Niacinamide Market is segmented on the basis of form and end user. Based on form the market is segmented into Granular, Powder and Liquid. Based on end user the market is segmented into Pharmaceuticals, Cosmeceuticals, Human Nutrition, Animal Nutrition and Others. The human nutrition is the leading segment trailed by animal nutrition owing to health benefits offered by the product.

Regional Outlook and Trend Analysis

Europe will keep on leading the worldwide niacin and niacinamide market, on the basis of revenue. Rising frequencies of downer cow syndrome (DCS) in dairy cattle, and expanding number of cases identified with childhood obesity are prime elements anticipated that would impact interest for niacin and niacinamide in the area. Lack of physical activity and overeating patterns are principle purposes behind overweight and obesity in youthful and in addition senior populace crosswise over European nations, which is turning into a major issue for the area's healthcare division.

Competitive Insights

The lading players in the market are DSM, Evonik Industries, Zhejiang NHU Co Ltd, Vertellus Specialties UK, Jubilant Life Sciences, Lonza Group, Fagron, Merck Group, Brother Enterprises, Bactolac Pharmaceutical Inc, BASF and Foodchem International Corporation. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

The Niacin and Niacinamide Market is segmented as follows-

By Form:

  • Granular
  • Powder
  • Liquid

By End User:

  • Pharmaceuticals
  • Cosmeceuticals
  • Human Nutrition
  • Animal Nutrition
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • South Africa
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2023?
  • What will be the industry market growth from 2017 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Niacin and Niacinamide Market, By Form, Estimates and Forecast, 2014-2023 ($Million)

·         Granular

·         Powder

·         Liquid

·         Niacin and Niacinamide Market, By End Use, Estimates and Forecast, 2014-2023 ($Million)

·         Pharmaceuticals

·         Cosmeceuticals

·         Human Nutrition

·         Animal Nutrition

·         Niacin and Niacinamide Market, By Region, Estimates and Forecast, 2014-2023 ($Million)

·         North America

§  North America Niacin and Niacinamide Market, By Country

o    U.S. Niacin and Niacinamide Market

o    Canada Niacin and Niacinamide Market

o    Mexico Niacin and Niacinamide Market

·         Europe

§  Europe Niacin and Niacinamide Market, By Country

o    Germany Niacin and Niacinamide Market

o    UK Niacin and Niacinamide Market

o    France Niacin and Niacinamide Market

o    Russia Niacin and Niacinamide Market

o    Italy Niacin and Niacinamide Market

o    Rest of Europe Niacin and Niacinamide Market

·         Asia-Pacific

§  Asia-Pacific Niacin and Niacinamide Market, By Country

o    China Niacin and Niacinamide Market

o    Japan Niacin and Niacinamide Market

o    South Korea Niacin and Niacinamide Market

o    India Niacin and Niacinamide Market

o    Southeast Asia Niacin and Niacinamide Market

o    Rest of Asia-Pacific Niacin and Niacinamide Market

·         South America

§  South America Niacin and Niacinamide Market

o    Brazil Niacin and Niacinamide Market

o    Argentina Niacin and Niacinamide Market

o    Columbia Niacin and Niacinamide Market

o    South Africa Niacin and Niacinamide Market

o    Rest of South America Niacin and Niacinamide Market

·         Middle East and Africa

§  Middle East and Africa Niacin and Niacinamide Market

o    Saudi Arabia Niacin and Niacinamide Market

o    UAE Niacin and Niacinamide Market

o    Egypt Niacin and Niacinamide Market

o    Nigeria Niacin and Niacinamide Market

o    South Africa Niacin and Niacinamide Market

o    Rest of MEA Niacin and Niacinamide Market

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2023)

4.1.2.  Canada Market States and Outlook (2017-2023)

4.1.3.  Mexico Market States and Outlook (2017-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2023)

4.2.2.  France Market States and Outlook (2017-2023)

4.2.3.  UK Market States and Outlook (2017-2023)

4.2.4.  Russia Market States and Outlook (2017-2023)

4.2.5.  Italy Market States and Outlook (2017-2023)

4.2.6.  Rest of Europe Market States and Outlook (2017-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2023)

4.3.2.  Japan Market States and Outlook (2017-2023)

4.3.3.  Korea Market States and Outlook (2017-2023)

4.3.4.  India Market States and Outlook (2017-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2017-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2023)

4.4.2.  Argentina Market States and Outlook (2017-2023)

4.4.3.  Columbia Market States and Outlook (2017-2023)

4.4.4.  Rest of South America Market States and Outlook (2017-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2023)

4.5.2.  UAE Market States and Outlook (2017-2023)

4.5.3.  Egypt Market States and Outlook (2017-2023)

4.5.4.  Nigeria Market States and Outlook (2017-2023)

4.5.5.  South Africa Market States and Outlook (2017-2023)

4.5.6.  Rest of MEA Market States and Outlook (2017-2023)

5.       Niacin and Niacinamide Market, By Form

5.1.       Introduction

5.2.       Global Niacin and Niacinamide Sales, Revenue and Market Share by Form (2017-2027)

5.2.1.  Global Niacin and Niacinamide Sales and Sales Share by Form (2017-2027)

5.2.2.  Global Niacin and Niacinamide Revenue and Revenue Share by Form (2017-2027)

5.3.       Granular

5.3.1.  Global Granular Sales and Growth Rate (2017-2027)

5.4.       Powder

5.4.1.  Global Powder Sales and Growth Rate (2017-2027)

5.5.       Liquid

5.5.1.  Global Liquid Sales and Growth Rate (2017-2027)

6.       Niacin and Niacinamide Market, By End User

6.1.       Introduction

6.2.       Global Niacin and Niacinamide Sales, Revenue and Market Share by End User (2017-2027)

6.2.1.  Global Niacin and Niacinamide Sales and Sales Share by End User (2017-2027)

6.2.2.  Global Niacin and Niacinamide Revenue and Revenue Share by End User (2017-2027)

6.3.       Pharmaceuticals

6.3.1.  Global Pharmaceuticals Sales and Growth Rate (2017-2027)

6.4.       Cosmeceuticals

6.4.1.  Global Cosmeceuticals Sales and Growth Rate (2017-2027)

6.5.       Human Nutrition

6.5.1.  Global Human Nutrition Sales and Growth Rate (2017-2027)

6.6.       Animal Nutrition

6.6.1.  Global Animal Nutrition Sales and Growth Rate (2017-2027)

7.       Niacin and Niacinamide Market, By Region

7.1.       Introduction

7.2.       Global Niacin and Niacinamide Sales, Revenue and Market Share by Regions

7.2.1.  Global Niacin and Niacinamide Sales by Regions (2017-2027)

7.2.2.  Global Niacin and Niacinamide Revenue by Regions (2017-2027)

7.3.       North America Niacin and Niacinamide by Countries

7.3.1.  North America Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.3.2.  North America Niacin and Niacinamide Revenue and Growth Rate (2017-2027)

7.3.3.  North America Niacin and Niacinamide Sales by Countries (2017-2027)

7.3.4.  North America Niacin and Niacinamide Revenue (Million USD) by Countries (2017-2027)

7.3.5.  U.S.

7.3.5.1.    United States Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.3.5.2.    United States Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.6.  Canada

7.3.6.1.    Canada Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.3.6.2.    Canada Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.7.  Mexico

7.3.7.1.    Mexico Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.3.7.2.    Mexico Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.       Europe Niacin and Niacinamide by Countries

7.4.1.  Europe Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.4.2.  Europe Niacin and Niacinamide Revenue and Growth Rate (2017-2027)

7.4.3.  Europe Niacin and Niacinamide Sales by Countries (2017-2027)

7.4.4.  Europe Niacin and Niacinamide Revenue (Million USD) by Countries (2017-2027)

7.4.5.  Germany

7.4.5.1.    Germany Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.4.5.2.    Germany Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  UK

7.4.6.1.    UK Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.4.6.2.    UK Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  France

7.4.7.1.    France Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.4.7.2.    France Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Russia

7.4.8.1.    Russia Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.4.8.2.    Russia Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.9.  Italy

7.4.9.1.    Italy Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.4.9.2.    Italy Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.10.      Rest of Europe

7.4.10.1. Rest of Europe Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.4.10.2. Rest of Europe Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.       Asia-Pacific

7.5.1.  Asia-Pacific Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Niacin and Niacinamide Revenue and Growth Rate (2017-2027)

7.5.3.  Asia-Pacific Niacin and Niacinamide Sales by Countries (2017-2027)

7.5.4.  Asia-Pacific Niacin and Niacinamide Revenue (Million USD) by Countries (2017-2027)

7.5.5.  China

7.5.5.1.    China Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.5.5.2.    China Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  Japan

7.5.6.1.    Japan Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.5.6.2.    Japan Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.3.     

7.5.7.  Korea

7.5.7.1.    Korea Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.5.7.2.    Korea Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  India

7.5.8.1.    India Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.5.8.2.    India Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.9.  Southeast Asia

7.5.9.1.    Southeast Asia Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.5.9.2.    Southeast Asia Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.10.      Rest of Asia-Pacific

7.5.10.1. Rest of Asia-Pacific Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.5.10.2. Rest of Asia-Pacific Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.       South America

7.6.1.  South America Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.6.2.  South America Niacin and Niacinamide Revenue and Growth Rate (2017-2027)

7.6.3.  South America Niacin and Niacinamide Sales by Countries (2017-2027)

7.6.4.  South America Niacin and Niacinamide Revenue (Million USD) by Countries (2017-2027)

7.6.5.  Brazil

7.6.5.1.    Brazil Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.6.5.2.    Brazil Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Argentina

7.6.6.1.    Argentina Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.6.6.2.    Argentina Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.7.  Columbia

7.6.7.1.    Columbia Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.6.7.2.    Columbia Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.8.  Rest of South America

7.6.8.1.    Rest of South America Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.6.8.2.    Rest of South America Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.       Middle East and Africa

7.7.1.  Middle East and Africa Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Niacin and Niacinamide Revenue and Growth Rate (2017-2027)

7.7.3.  Middle East and Africa Niacin and Niacinamide Sales by Countries (2017-2027)

7.7.4.  Middle East and Africa Niacin and Niacinamide Revenue (Million USD) by Countries (2017-2027)

7.7.5.  Saudi Arabia

7.7.5.1.    Saudi Arabia Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.7.5.2.    Saudi Arabia Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  United Arab Emirates

7.7.6.1.    United Arab Emirates Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.7.6.2.    United Arab Emirates Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  Egypt

7.7.7.1.    Egypt Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.7.7.2.    Egypt Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Nigeria

7.7.8.1.    Nigeria Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.7.8.2.    Nigeria Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  South Africa

7.7.9.1.    South Africa Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.7.9.2.    South Africa Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.10.      Rest of Middle East and Africa

7.7.10.1. Rest of Middle East and Africa Niacin and Niacinamide Sales and Growth Rate (2017-2027)

7.7.10.2. Rest of Middle East and Africa Niacin and Niacinamide Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.         Merck KGaA

8.1.1.  Business Overview

8.1.2.  Form Portfolio

8.1.3.  Strategic Developments

8.1.4.  Sales, Revenue and Market Share

8.2.       Lonza Group AG

8.2.1.  Business Overview

8.2.2.  Form Portfolio

8.2.3.  Strategic Developments

8.2.4.  Sales, Revenue and Market Share

8.3.       Koninklijke DSM N.V.

8.3.1.  Business Overview

8.3.2.  Form Portfolio

8.3.3.  Strategic Developments

8.3.4.  Sales, Revenue and Market Share

8.4.       BASF SE

8.4.1.  Business Overview

8.4.2.  Form Portfolio

8.4.3.  Strategic Developments

8.4.4.  Sales, Revenue and Market Share

8.5.       Bactolac Pharmaceutical Inc.

8.5.1.  Business Overview

8.5.2.  Form Portfolio

8.5.3.  Strategic Developments

8.5.4.  Sales, Revenue and Market Share

8.6.       Evonik Industries AG

8.6.1.  Business Overview

8.6.2.  Form Portfolio

8.6.3.  Strategic Developments

8.6.4.  Sales, Revenue and Market Share

8.7.       Fagron NV

8.7.1.  Business Overview

8.7.2.  Form Portfolio

8.7.3.  Strategic Developments

8.7.4.  Sales, Revenue and Market Share

8.8.       Jubilant Life Sciences Limited

8.8.1.  Business Overview

8.8.2.  Form Portfolio

8.8.3.  Strategic Developments

8.8.4.  Sales, Revenue and Market Share

8.9.       Zhejiang NHU Company Ltd.

8.9.1.  Business Overview

8.9.2.  Form Portfolio

8.9.3.  Strategic Developments

8.9.4.  Sales, Revenue and Market Share

8.10.    Brother Enterprises Holding Co., Ltd.

8.10.1.      Business Overview

8.10.2.      Form Portfolio

8.10.3.      Strategic Developments

8.10.4.      Sales, Revenue and Market Share

9.       Global Niacin and Niacinamide Market Competition, by Manufacturer

9.1.       Global Niacin and Niacinamide Sales and Market Share by Manufacturer (2017-2017)

9.2.       Global Niacin and Niacinamide Revenue and Market Share by Manufacturer (2017-2017)

9.3.       Global Niacin and Niacinamide Price by Region (2017-2017)

9.4.       Top 5 Niacin and Niacinamide Manufacturer Market Share

9.5.       Market Competition Trend

10.   Niacin and Niacinamide Market Forecast (2027-2023)

10.1.    Global Niacin and Niacinamide Sales, Revenue (Millions USD) and Growth Rate (2027-2023)

10.2.    Niacin and Niacinamide Market Forecast by Regions (2027-2023)

10.2.1.      North America Niacin and Niacinamide Market Forecast (2027-2023)

10.2.1.1. United States Niacin and Niacinamide Market Forecast (2027-2023)

10.2.1.2. Canada Niacin and Niacinamide Market Forecast (2027-2023)

10.2.1.3. Mexico Niacin and Niacinamide Market Forecast (2027-2023)

10.2.2.      Europe Niacin and Niacinamide Market Forecast (2027-2023)

10.2.2.1. Germany Niacin and Niacinamide Market Forecast (2027-2023)

10.2.2.2. United Kingdom Niacin and Niacinamide Market Forecast (2027-2023)

10.2.2.3. France Niacin and Niacinamide Market Forecast (2027-2023)

10.2.2.4. Russia Niacin and Niacinamide Market Forecast (2027-2023)

10.2.2.5. Italy Niacin and Niacinamide Market Forecast (2027-2023)

10.2.2.6. Rest of the Europe Niacin and Niacinamide Market Forecast (2027-2023)

10.2.3.      Asia-Pacific Niacin and Niacinamide Market Forecast (2027-2023)

10.2.3.1. China Niacin and Niacinamide Market Forecast (2027-2023)

10.2.3.2. Japan Niacin and Niacinamide Market Forecast (2027-2023)

10.2.3.3. Korea Niacin and Niacinamide Market Forecast (2027-2023)

10.2.3.4. India Niacin and Niacinamide Market Forecast (2027-2023)

10.2.3.5. Southeast Asia Niacin and Niacinamide Market Forecast (2027-2023)

10.2.3.6. Rest of Asia-Pacific Niacin and Niacinamide Market Forecast (2027-2023)

10.2.4.      South America Niacin and Niacinamide Market Forecast (2027-2023)

10.2.4.1. Brazil Niacin and Niacinamide Market Forecast (2027-2023)

10.2.4.2. Argentina Niacin and Niacinamide Market Forecast (2027-2023)

10.2.4.3. Columbia Niacin and Niacinamide Market Forecast (2027-2023)

10.2.4.4. Rest of South America Niacin and Niacinamide Market Forecast (2027-2023)

10.2.5.      Middle East and Africa Niacin and Niacinamide Market Forecast (2027-2023)

10.2.5.1. Saudi Arabia Niacin and Niacinamide Market Forecast (2027-2023)

10.2.5.2. UAE Niacin and Niacinamide Market Forecast (2027-2023)

10.2.5.3. Egypt Niacin and Niacinamide Market Forecast (2027-2023)

10.2.5.4. Nigeria Niacin and Niacinamide Market Forecast (2027-2023)

10.2.5.5. South Africa Niacin and Niacinamide Market Forecast (2027-2023)

10.2.5.6. Rest of MEA Niacin and Niacinamide Market Forecast (2027-2023)

10.3.    Niacin and Niacinamide Market Forecast by Form (2027-2023)

10.3.1.      Global Niacin and Niacinamide Sales Forecast by Form (2027-2023)

10.3.2.      Global Niacin and Niacinamide Sales Market Share Forecast by Form (2027-2023)

10.4.    Niacin and Niacinamide Market Forecast by End User (2027-2023)

10.4.1.      Global Niacin and Niacinamide Sales Forecast by End User (2027-2023)

10.4.2.      Global Niacin and Niacinamide Sales Market Share Forecast by End User (2027-2023)

List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Niacin and Niacinamide Market.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*